CLINICAL CORE
临床核心
基本信息
- 批准号:7318790
- 负责人:
- 金额:$ 34.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AreaBuprenorphineClinicClinicalClinical InvestigatorClinical ResearchDiseaseDrug abuseEnvironmentEvaluationFundingGeneticGoalsHealth PersonnelHeroin DependenceHumanInformed ConsentInpatientsMaintenanceMedicalMedicineMethadoneMolecular GeneticsMolecular NeurobiologyNew YorkNumbersNurse PractitionersNursesNursing ResearchOutpatientsPharmacotherapyPhysiciansProfessional counselorPsychologistPurposeResearchResearch Ethics CommitteesScreening procedureSiteSocial WorkersStudy SubjectTrainingTraining and EducationUniversitiesUniversity Hospitalsfollow-upinterestperformance siteprogramsresponse
项目摘要
The Clinical Research Core is a fundamental and essential core of our NIH-NIDA funded Center. The goals
of the core are:
1) To provide highly trained staff (physicians, nurse practitioners, nurses, and assistants for research) at all
levels to perform the rigorous inpatient molecular neurobiology studies as detailed in Project 4, as well as an
outpatient site for performance of related genetic studies, as well as for subject screening, evaluation, and
follow-up.
2) The second goal is to develop or maintain strong on-site relationships with a limited number of large,
successful programs delivering primarily pharmacotherapy for heroin addiction using methadone maintenance
or buprenorphine maintenance for:
a. Recruitment of subjects for studies at The Rockefeller University Hospital
b. In some cases, conducting onsite human molecular genetics ascertainment studies with local clinic IRBs'
Informed Consent, as well as Rockefeller University IRB Informed Consent, both signed
c. To identify new problems, including psychiatric and medical problems, new drug abuse problems
confronting these groups, as well as any unexpected positive or adverse responses to specific treatments. A
broad spectrum of subjects in the greater New York area are used for recruitment. Our related clinic in Las
Vegas, NV, is used primarily for identification of problems and confirming or refuting the generalizability of
observations made in the greater New York area in another part of our nation.
3) The third goal is to provide a nurturing and rigorous environment for the training of clinical investigators,
including physicians, nurse practitioners, research nurses, counselors, psychologists, and a wide variety of
healthcare personnel, including social workers and counselors interested in becoming directly involved in
addictive diseases research or for the purpose of general education and training in research medicine and/or
addictive diseases treatment.
临床研究核心是我们NIH-NIDA资助中心的基础和必不可少的核心。目标
核心部分包括:
1)提供训练有素的工作人员(医生、执业护士、护士和研究助理)
进行项目4中详细说明的严格的住院患者分子神经生物学研究的水平,以及
门诊站点,用于相关基因研究的执行以及受试者筛选、评估和
后续行动。
2)第二个目标是与有限数量的大型、
成功的项目主要使用美沙酮维持对海洛因成瘾的药物治疗
或丁丙诺啡维持费:
A.在洛克菲勒大学医院招募研究对象
B.在某些情况下,与当地临床IRBs进行现场人类分子遗传学研究
知情同意书,以及洛克菲勒大学IRB知情同意书,均已签署
C.确定新问题,包括精神和医疗问题、新的药物滥用问题
面对这些群体,以及对特定治疗的任何意想不到的积极或不良反应。一个
大纽约地区的广泛科目被用于招聘。我们在拉斯维加斯的相关诊所
拉斯维加斯,内华达州,主要用于识别问题和确认或驳斥的概括性
在我们国家另一个地区的大纽约地区所做的观察。
3)第三个目标是为临床研究人员的培训提供一个培育和严格的环境,
包括内科医生、执业护士、研究护士、咨询师、心理学家和各种各样的
医护人员,包括有兴趣直接参与的社会工作者和顾问
成瘾性疾病研究或用于研究医学和/或研究方面的一般教育和培训
成瘾性疾病治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY J KREEK其他文献
MARY J KREEK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY J KREEK', 18)}}的其他基金
DISPOSITION, METABOLISM & PROCESSING OF OPIATE AGONISTS, ANTAGONISTS & OPIOIDS
性格、新陈代谢
- 批准号:
8361484 - 财政年份:2011
- 资助金额:
$ 34.38万 - 项目类别:
CO2-INDUCED ANESTHESIA RESULTS IN RAPID INCREASE IN PLASMA LEVELS OF VASOPRESSIN
二氧化碳诱导麻醉导致血浆加压素水平快速升高
- 批准号:
8361542 - 财政年份:2011
- 资助金额:
$ 34.38万 - 项目类别:
CO2-INDUCED ANESTHESIA RESULTS IN RAPID INCREASE IN PLASMA LEVELS OF VASOPRESSIN
二氧化碳诱导麻醉导致血浆加压素水平快速升高
- 批准号:
8169171 - 财政年份:2010
- 资助金额:
$ 34.38万 - 项目类别:
DISPOSITION, METABOLISM & PROCESSING OF OPIATE AGONISTS, ANTAGONISTS & OPIOIDS
性格、新陈代谢
- 批准号:
8169099 - 财政年份:2010
- 资助金额:
$ 34.38万 - 项目类别:
DISPOSITION, METABOLISM & PROCESSING OF OPIATE AGONISTS, ANTAGONISTS & OPIOIDS
性格、新陈代谢
- 批准号:
7954050 - 财政年份:2009
- 资助金额:
$ 34.38万 - 项目类别:
CO2-INDUCED ANESTHESIA RESULTS IN RAPID INCREASE IN PLASMA LEVELS OF VASOPRESSIN
二氧化碳诱导麻醉导致血浆加压素水平快速升高
- 批准号:
7954140 - 财政年份:2009
- 资助金额:
$ 34.38万 - 项目类别:
DISPOSITION, METABOLISM & PROCESSING OF OPIATE AGONISTS, ANTAGONISTS & OPIOIDS
性格、新陈代谢
- 批准号:
7722184 - 财政年份:2008
- 资助金额:
$ 34.38万 - 项目类别:
ALTERATIONS OF NEUROENDOCRINE STRESS RESPONSIVITY IN SPECIFIC ADDICTIVE DISEAS...
特定成瘾疾病中神经内分泌应激反应的改变...
- 批准号:
7318814 - 财政年份:2007
- 资助金额:
$ 34.38万 - 项目类别:
RESEARCH ADMINISTRATION, TRAINING, CAREER DEVELOPMENT AND MENTORING CORE
研究管理、培训、职业发展和指导核心
- 批准号:
7318715 - 财政年份:2007
- 资助金额:
$ 34.38万 - 项目类别:
HIV and Psychiatric Comorbidity: Selected Genetic and Epigenetic Factors
HIV 和精神科合并症:选定的遗传和表观遗传因素
- 批准号:
7880880 - 财政年份:2006
- 资助金额:
$ 34.38万 - 项目类别:
相似海外基金
Elucidating High Oral Fluid Exposure Mechanisms of Buprenorphine to Reduce Dental Caries
阐明丁丙诺啡的高口腔液暴露机制以减少龋齿
- 批准号:
10765181 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Examining injectable buprenorphine implementation strategies in low-threshold and primary care settings
检查低阈值和初级保健环境中注射丁丙诺啡的实施策略
- 批准号:
10591424 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Building and Implementing Best Practices for Buprenorphine Initiation in the Setting of Fentanyl Use
在芬太尼使用情况下建立和实施丁丙诺啡起始的最佳实践
- 批准号:
10721763 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Providers and Older Pain Patients with Prescription Opioid Dependence: A Qualitative Study to Understand Barriers to Opioid Taper, Cessation, and Transition to Buprenorphine.
具有处方阿片类药物依赖性的提供者和老年疼痛患者:一项定性研究,旨在了解阿片类药物逐渐减少、戒断和过渡到丁丙诺啡的障碍。
- 批准号:
10671358 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9).
标准和高剂量 ED 丁丙诺啡诱导。
- 批准号:
10938754 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
FY23. TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/24.
23 财年。
- 批准号:
10938755 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Long acting biodegradable buprenorphine depots
长效可生物降解丁丙诺啡储库
- 批准号:
10757180 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Understanding the Association between Sublingual Buprenorphine and Oral Health Outcomes
了解舌下含服丁丙诺啡与口腔健康结果之间的关联
- 批准号:
10765299 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
A comparative effectiveness trial of sublingual versus extended-release buprenorphine with individuals leaving a carceral setting
舌下含服与缓释丁丙诺啡对离开监狱环境的个体的有效性比较试验
- 批准号:
10718889 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Sequential Trial of Adding Buprenorphine, Cognitive Behavioral Treatment, and Transcranial Magnetic Stimulation to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain (ACTION)
添加丁丙诺啡、认知行为治疗和经颅磁刺激以改善长期阿片类药物治疗慢性疼痛的效果的序贯试验 (ACTION)
- 批准号:
10717184 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别: